Abstract:Objective To observe the change of peripheral blood lymphocytes subsets in patients with active ulcerative colitis (UC) and explore its clinical significance. Methods The clinical data and lymphocyte subsets of 40 active UC patients who admitted to the Department of Gastroenterology, Peking University First Hospital,from June 2007 to January 2010 were retrospectively analyzed. Patients who had previously used immunosuppressants or tumor necrosis factor monoclonal antibody were excluded. Seventy-nine subjects with health examination served as controls. Peripheral blood lymphocyte subsets detected included total T cells, CD4 + T cells, CD8 + T cells, B cells, and NK cells. Only the first detection results of UC patients were used for analysis. Results The proportion of total T cells for UC patients (73.60% ± 8.35% ) was significantly higher than the controls (69. 76% ±7.37%) (P =0.012). CD8+T cell ratio (35.53% ± 10.99%) was significantly higher than the controls ( 30. 56% ± 6. 75 % ) ( P = 0. 011 ). When the UC patients were stratified according to inflammatory involvement,the total T cells, CD8 +T cell, and NK cell ratio were significantly different among pancolitis, non-pancolitis, and the controls ( all P ＜ 0. 05 ). When the UC patients were stratified according to the disease course, the total T cells and CD8 + T cell ratio were significantly different among chronic recurrent/persistent, onset, and the controls ( both P ＜ 0.05 ). When the UC patients were stratified according to the extraintestinal manifestations, the total T cells and CD8 + T cell ratio were significantly different among those with extraintestinal manifestations, those without extraintestinal manifestations, and the controls ( both P ＜ 0.05 ). Conclusions The proportion of total T cells and CD8 + T cells increase in UC patients. Such immune abnormalities are even more distinctive in those UC patients who suffer from pancolitis or chronic recurrent/persistent type or those with extraintestinal manifestations.

The clinical research of T help cell subsets in Urinary Tract Infection patients

Clinical Significance of Lymphocyte Subsets Changes in the Active Stage of Ulcerative Colitis: a Retrospective Study

[Peripheral T Cell Subsets in Chronic Tonsillitis Patients].

Alterations and clinical significance of peripheral blood T lymphocyte subsets in patients with septic acute kidney injury

Expression of CD4~+ CD25~+ regulatory T cells in human bladder carcinoma and its clinical significance

Investation of Lymphocyte Subsets and Related Cytokines of Peripherm Blood in Patients with Chronic Immue Thrombocytopenia

Phenotypic Analysis of Th Cells in Colonic Mucosa and Peripheral Blood of Patients with Ulcerative Colitis

Alteration of Complement,T lymphocyte subgroups and Immunoglobulins in Patients with Ulcerative Colitis in Peripheral Blood

Study on Peripheral Blood T Lymphocyte Subsets of Patients with Lung Cancer and Lung Infection

The Imbalance of Th17/Treg in Patients with Uterine Cervical Cancer.

Phenotypic Analysis of Lymphocytes in Patients with Ulcerative Colitis

The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients

Study on the subset of T lymphocyte and CD4+CD25+ regulatory cells in peripheral blood of malignancies

Changes of Th17 and Treg Cell Ratio in the Peripheral Blood of Patients with Benign Prostatic Hyperplasia

Study on CD4+CD25+Foxp3+T Cells and Clinical Status of Patients after Renal Transplantation

Research of Relationship Between HIV/AIDS Syndrome Differentiation Type of TCM and T Lymphocyte Subsets

The Th cells proportions in peripheral blood of tuberculosis patients

Comparison of regulatory T cell with cytotoxic T lymphocyte in peripheral blood with bladder cancer before surgery

Detection and Clinical Significance of Treg and Th1,Th2 Cells in Peripheral Blood of Patients with Immune Thrombocytopenia

Clinical Significance of T Lymphocyte Subsets in Patients with Acute Leukemia Before and after Chemotherapy

T Follicular Helper Cells in Peripheral Blood of Patients with Immune Thrombocytopenic Purpura